Anxiolytic effect of methylene blue microinjected into the dorsal periaqueductal gray matter

Brazilian Journal of Medical and Biological Research

Volumn 32, Issue 12, 1999, Pages 1529-1532

  De Oliveira, R W ^a   Guimaraes F S ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Animal model; Anxiety; Elevated plus maze; Nitric oxide

Indexed keywords

CYCLIC GMP; METHYLENE BLUE;

ANIMAL EXPERIMENT; ANXIETY; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; MALE; MAZE TEST; MICROINJECTION; NONHUMAN; PERIAQUEDUCTAL GRAY MATTER; RAT; TRANQUILIZING ACTIVITY;

ANIMALIA;

EID: 0343851083     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X1999001200012     Document Type: Article

References (20)

1. Graeff FG (1991). Neurotransmitters in the dorsal periaqueductal gray and animal models of panic anxiety. In: Briley M & File SE (Editors), New Concepts in Anxiety. McMillian, London, 288-312
2. Schenberg LC, De Aguiar JC & Graeff FG (1983). GABA modulation of defence reaction induced by brain electrical stimulation Physiology and Behavior, 31: 429-437.
3. Graeff FG, Silveira MC, Nogueira RL, Audi EA & Oliveira RM (1993). Role of amygdala and periaqueductal gray in anxiety and panic. Behavioural Brain Research, 58: 123-127.
4. Bandler R (1988). Brain mechanisms of aggression as revealed by electrical and chemical stimulation: suggestion of a central role for the midbram periaqueductal gray region. In: Epstein A & Horrison A (Editors), Progress in Psychobiology and Physiological Psychology. Vol 13. Academic Press, New York, 67-154.
5. Guimarães FS, Carobrez AP, De Aguiar JC & Graeff FG (1991). Anxiolytic effect in the elevated plus-maze of NMDA receptor antagonist AP7 microinjected into the dorsal periaqueductal gray. Psychopharmacology, 103: 91-94.
6. Garthwaite J, Charles SL & Chess-Williams R (1988). Endothelium-derivated relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain. Nature, 336: 385-388.
7. Garthwaite J (1991). Glutamate, nitric oxide and cell-cell signalling in the nervous system. Trends in Neurosciences, 14: 60-67.
8. Vincent SR & Kimura H (1992). Histochemical mapping of nitric oxide synthase in the rat brain. Neuroscience, 46: 755-784.
9. Guimarães FS, de Aguiar JC, Del Bel EA & Ballejo GO (1994). Anxiolytic effect of nitric oxide synthase inhibitors nnicroinjected into the dorsal central gray. NeuroReport, 5: 1929-1931.
10. Del Bel EA, de Oliveira RMW & Guimarães FS (1998). Role of nitric oxide on emotional and motor behaviour. In: Torre V & Nicholls J (Editors), Proceedings of the NATO ASI School 'Neuronal Circuits and Networks'. Springer Verlag, Berlin, 109-124.
11. Ignarro LJ & Kadowitz PJ (1985). The pharmacological and physiological role of cyclic GMP in vascular smooth muscle relaxation. Annual Review of Pharmacology and Toxicology, 25: 171-191.
12. Moncada S, Palmer RMJ & Higgs EA (1991). Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacological Reviews, 43: 109-142.
13. File SE (1992). Behavioural detection of anxiolytic action. In: Elliot JM, Heal DJ & Marsden CA (Editors), Experimental Approaches to Anxiety and Depression. John Wiley & Sons, New York, 25-44.
14. Eroglu L & Çaglayan B (1997). Anxiolytic and antidepressant properties of methylens blue in animal models. Pharmacological Research, 36: 381-385.
15. Kelner MJ, Bagnell R, Hale B & Alexander NM (1988). Methylene blue competes with paraquat for reduction by flavo-enzymes resulting in decreased superoxide production in the presence of heme proteins. Archives of Biochemistry and Biophysics, 262: 422-426.
16. Mayer B, Brunner F & Schmidt K (1993). Inhibition of nitric synthases by methylene blue. Biochemical Pharmacology, 45: 367-374.
17. Wolin MS, Cherry PD, Rodenburg JM, Messina EJ & Kaley G (1990). Methylene blue inhibits vasodilatation of skeletal muscle arterioles to acetylcholine and nitric oxide via the extracellular generation of superoxide anion. Journal of Pharmacology and Experimental Therapeutics, 254: 872-876.
18. Chiavegatto C, Scavone C & Canteras NS (1998). Nitric oxide synthase activity in the dorsal periaqueductal gray of rats expressing innate fear response. NeuroReport, 4; 571-576.
19. Volke V, Koks S, Vasar E, Bourin M, Bnedwyn J & Mannisto PT (1995). Inhibition of nitric syrthases causes anxiolytic-like behaviour in an elevated plus-maze. NeuroReport, 6: 1413-1416.
20. Matheus MG, Nogueira RL, Carobrez AP, Graeff FG & Guimarães FS (1994). Anxiolytic effect of glycine antagonists microinjected into the dorsal periaqueductal grey. Psychopharmacology, 113: 565-569.